Background and objective Advances in molecular diagnostics have ushered in a new era for
patients with prostate, renal, and urothelial cancers, with novel radiographic and molecular …

Array-based micro-or nanoscale substrates are particularly attractive for biomolecular
sensing due to the periodicity of the engineered nanostructures that provide impressively …

Protein post-translational modifications (PTMs) represent a crucial aspect of cellular
regulation, occurring after protein synthesis from mRNA. These modifications, which include …

Renal cell carcinoma (RCC) remains a formidable diagnostic challenge, especially in the
context of small renal masses. The quest for non-invasive screening tools and biomarkers …

Renal cell carcinoma (RCC) is recognized as one of the three primary malignant tumors
affecting the urinary system, posing a significant risk to human health and life. Despite …

Clear-cell renal cell carcinoma (ccRCC) is a common urological malignancy with an
increasing incidence. The development of molecular biomarkers that can predict the …

Predictive biomarkers of response to immune checkpoint-based therapies (ICI) remain a
critically unmet need in the management of advanced renal cell carcinoma (RCC). The …

目的探讨肾透明细胞癌中半乳糖凝集素-1 (Galectin-1) 蛋白的表达变化, 并评估其在患者预后
判断方面的潜在价值. 方法采用组织微阵列和免疫组织化学技术对173 例肾透明细胞癌组织及其 …

Advancements in DNA nanotechnology have led to new exciting ways to detect cell-free
tumor biomarkers, revolutionizing cancer diagnostics. This article comprehensively reviews …

Background There are multiple first-line treatment options in the management of metastatic
renal cell carcinoma (mRCC). In the face of this broad treatment landscape, a reliable …